Dominican Republic vs French Guiana: Number of clinical trials
Dominican Republic
1 trials
in 2024
French Guiana
1 trials
in 2024
Dominican Republic rank
127th
French Guiana rank
127th
Number of clinical trials over time
- Dominican Republic
- French Guiana
How they compare
Dominican Republic currently reports 1 trials against 1 trials in French Guiana, a difference of 0 trials.
The two have swapped places 1 time across 6 shared years of data; in 2015 it was Dominican Republic ahead.
Dominican Republic ranks 127th and French Guiana ranks 127th of 153 countries.
Across the 2 decades both report, Dominican Republic averaged higher in 1 and French Guiana in 1.
Head to head by decade
| Decade | Dominican Republic | French Guiana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.5 trials | 1.5 trials | 2 trials | Dominican Republic |
| 2020s | 2.25 trials | 2.75 trials | 0.5 trials | French Guiana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Dominican Republic or French Guiana?
- Dominican Republic, at 1 trials against 1 trials in French Guiana as of 2024.
- What is the difference in number of clinical trials between Dominican Republic and French Guiana?
- 0 trials, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and French Guiana?
- 6 years are reported by both, from 2015 to 2024.
- How do Dominican Republic and French Guiana rank globally for number of clinical trials?
- Dominican Republic ranks 127th and French Guiana ranks 127th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) β with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.